Ticker LaunchReverse merger · Completed · GCTK
Lōkahi Therapeutics
Reverse merger with Glucotrack, Inc. (GCTK)
Lōkahi Therapeutics merged into Glucotrack, Inc. (GCTK), a Nasdaq-listed medical device company, in a reverse merger that takes the private company public. The agreement was signed and the deal closed on the same day, Jul 14, 2026. The combined company trades as Glucotrack, Inc. (GCTK) on Nasdaq.
Glucotrack, Inc. combines with Lōkahi Therapeutics, whose ai2-driven platform sources, develops and advances therapeutic assets, creating a Lōkahi-controlled public platform for repeatable asset development. Lōkahi holders receive common and convertible preferred stock.
- Status
- Completed
- Private company
- Lōkahi Therapeutics
- Public company
- Glucotrack, Inc. (GCTK)
- Public company business before
- Nasdaq-listed medical device company
- Announced
- Signed and closed the same day
- Closed
- Jul 14, 2026
- Combined company
- Glucotrack, Inc. (GCTK)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Form 8-K (completion of acquisition) Jul 15, 2026
- Press release (Exhibit 99)
- All filings on EDGAR CIK 1506983
Other completed reverse mergers
- Light Across, Inc.into Sharing Economy International Inc. · Aug 2, 2026
- Yarrow Bioscience, Inc.into VYNE Therapeutics Inc. · Jul 27, 2026
- Avid Gold Ltdinto Nu-Med Plus, Inc. · Jul 8, 2026
- House of Dogeinto Brag House Holdings, Inc. · Jun 30, 2026
- Aeternum Health LLCinto Shorepower Technologies Inc. · Jun 30, 2026
- CIM Group, LLC real assets management businessinto CIM Real Estate Finance Trust, Inc. · Jun 29, 2026